Sodium alginate

DRUG4 trials

Sponsors

Chang Gung Memorial Hospital, TTY Biopharm, Kyungpook National University Hospital

Conditions

Gastroesophageal Reflux DiseaseGastrointestinal SymptomHeartburnLaryngopharyngeal RefluxSleep Disturbance

Phase 3

Efficacy and Safety of Sodium Alginate Oral Suspension to Treat Non-erosive Gastro-esophageal Reflux Disease

CompletedNCT01338077

Chang Gung Memorial HospitalGastroesophageal Reflux Disease, Heartburn

Start: 2010-10-31End: 2012-01-31Updated: 2012-02-10

Efficacy and Safety of Alginos Oral Suspension to Treat Laryngopharyngeal Reflux

CompletedNCT01450748

TTY BiopharmLaryngopharyngeal Reflux

Start: 2011-10-31End: 2015-03-31Updated: 2015-06-08

Phase 4

Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep Disturbances

Chang Gung Memorial HospitalGastroesophageal Reflux Disease, Heartburn, Sleep Disturbance

Start: 2014-11-30End: 2016-06-30Target: 340Updated: 2014-11-19

The Effect of Lamina-G on Gastrointestinal Symptom After Gastric Biopsy

CompletedNCT04134364

Kyungpook National University HospitalGastrointestinal Symptom

Start: 2017-03-27End: 2019-09-10Updated: 2020-04-24

Related Papers

Randomised clinical trial: sodium alginate oral suspension is non-inferior to omeprazole in the treatment of patients with non-erosive gastroesophageal disease

Alimentary Pharmacology & Therapeutics2013-09-1148 citations